Meta Platforms
META
Coinbase
COIN
Amazon
AMZN
MicroStrategy
MSTR
Apple
AAPL
US Stock MarketDetailed Quotes
ADIL Adial Pharmaceuticals
- 1.0500
- -0.0200-1.87%
Trading Dec 3 11:27 ET
6.73MMarket Cap-317P/E (TTM)
1.1800High1.0401Low760.53KVolume1.1100Open1.0700Pre Close846.62KTurnover12.77%Turnover RatioLossP/E (Static)6.41MShares4.169952wk High1.14P/B6.25MFloat Cap0.765052wk Low--Dividend TTM5.95MShs Float236.0000Historical High--Div YieldTTM13.08%Amplitude0.7650Historical Low1.1130Avg Price1Lot Size
Adial Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -21.79%-1.69M | -28.68%-2.15M | -5.74%-1.63M | 32.47%-5.8M | 14.20%-1.2M | 43.82%-1.39M | 24.69%-1.67M | 38.40%-1.54M | 28.08%-8.59M | 40.82%-1.4M |
| Net income from continuing operations | -62.63%-2.19M | -62.82%-2.46M | -189.15%-6.48M | 35.14%-7M | 25.31%-1.9M | 47.17%-1.35M | 45.83%-1.51M | 22.97%-2.24M | 44.42%-10.8M | 56.27%-2.55M |
| Operating gains losses | --31.02K | --222.47K | --189.87K | --193.88K | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 0.71%142 | 0.00%141 | 0.00%141 | 0.00%564 | 0.00%141 | 0.00%141 | 100.98%141 | -99.04%141 | -98.98%564 | -99.14%141 |
| Deferred tax | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Other non cash items | --0 | --0 | --4.46M | --51.9K | --0 | --0 | ---- | ---- | ---- | ---- |
| Change In working capital | 189.25%278.28K | 87.88%-114.85K | -112.43%-30.1K | 32.28%-794.21K | -45.76%222.91K | 35.29%-311.81K | -43.42%-947.49K | 154.89%242.19K | -180.08%-1.17M | -64.50%410.96K |
| -Change in prepaid assets | 41.52%-221.21K | -6.99%122.76K | -52.22%60.24K | -144.32%-22.16K | -36.69%98.01K | -25.97%-378.24K | 83.72%131.99K | 2.01%126.09K | -85.09%49.99K | -61.86%154.8K |
| -Change in payables and accrued expense | 136.60%157.16K | 110.11%109.15K | -177.81%-90.35K | 36.86%-772.05K | -51.24%124.9K | 136.57%66.43K | -45.04%-1.08M | 120.99%116.11K | -204.82%-1.22M | -66.42%256.16K |
| -Change in other working capital | --342.32K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | 0 | 0 | 0 | 61.29%-1M | 94.92%-17.59K | 0 | -225.02K | -760.84K | -2.59M | -346.44K |
| Operating cash flow | -21.79%-1.69M | -13.39%-2.15M | 29.26%-1.63M | 39.15%-6.81M | 30.17%-1.22M | 59.14%-1.39M | 46.40%-1.89M | 7.93%-2.3M | 6.39%-11.19M | 26.22%-1.75M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 1.5M | 350K | 350K | 0 | 0 | ||||
| Net other investing changes | ---- | ---- | ---- | --1.5M | --350K | --350K | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | ---- | ---- | --1.5M | --350K | --350K | ---- | ---- | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 2,503.61%3.61M | 708,677.59%411.09K | 527.33%3.82M | -54.72%4.13M | 3.38M | 138.67K | -96.89%58 | -93.32%609.61K | -33.12%9.13M | 0 |
| Net common stock issuance | 2,472.79%3.61M | --411.09K | --0 | -91.78%749.94K | --0 | --140.33K | --0 | -93.32%609.61K | -22.35%9.12M | --0 |
| Proceeds from stock option exercised by employees | --0 | --0 | --3.82M | 181,337.80%3.38M | --3.38M | --0 | --58 | --0 | -99.90%1.87K | --0 |
| Net other financing activities | ---- | ---- | ---- | ---1.66K | --0 | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 2,503.61%3.61M | 708,677.59%411.09K | 527.33%3.82M | -54.72%4.13M | --3.38M | --138.67K | -96.89%58 | -93.32%609.61K | -33.12%9.13M | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 169.91%3.29M | 117.29%5.03M | -29.35%2.83M | -33.99%4M | -94.51%315.88K | -86.70%1.22M | -81.78%2.31M | -33.99%4M | 37.74%6.06M | -19.88%5.75M |
| Current changes in cash | 312.37%1.92M | -58.72%-1.74M | 230.12%2.2M | 42.99%-1.17M | 243.43%2.51M | 73.49%-902.33K | 69.02%-1.09M | -125.49%-1.69M | -224.04%-2.06M | -56.60%-1.75M |
| End cash Position | 1,547.57%5.2M | 169.91%3.29M | 117.29%5.03M | -29.35%2.83M | -29.35%2.83M | -94.51%315.88K | -86.70%1.22M | -81.78%2.31M | -33.99%4M | -33.99%4M |
| Free cash flow | -21.79%-1.69M | -13.39%-2.15M | 29.26%-1.63M | 39.15%-6.81M | 30.17%-1.22M | 59.14%-1.39M | 46.40%-1.89M | 7.93%-2.3M | 6.89%-11.19M | 26.22%-1.75M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.